1
|
Li XL, Adi D, Wu Y, Aizezi A, Li YP, Kerem M, Wei X, Liu F, Ma X, Ma YT. A nomogram to predict ventricular thrombus in dilated cardiomyopathy patients. J Thromb Thrombolysis 2024; 57:29-38. [PMID: 37351822 PMCID: PMC10830674 DOI: 10.1007/s11239-023-02846-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 06/05/2023] [Indexed: 06/24/2023]
Abstract
BACKGROUND VT (Ventricular Thrombus) is a serious complication of dilated cardiomyopathy (DCM). Our goal is to develop a nomogram for personalized prediction of incident VT in DCM patients. METHODS 1267 patients (52.87 ± 11.75 years old, 73.8% male) were analyzed retrospectively from January 01, 2015, to December 31, 2020. A nomogram model for VT risk assessment was established using minimum absolute contraction and selection operator (LASSO) and multivariate logistic regression analysis, and its effectiveness was validated by internal guidance. The model was evaluated by the area under the receiver operating characteristic curve (AUC), calibration curves, and decision curve analysis (DCA). We compared the performance in predicting VT between nomogram and CHA2DS2, CHA2DS2- VASc or ATRIA by AUC, akaike information criterion (AIC), bayesian information criterion (BIC), net reclassification index (NRI), and integrated discrimination index (IDI). RESULTS 89 patients (7.02%) experienced VT. Multivariate logistic regression analysis revealed that age, left ventricular ejection fraction (LVEF), uric acid (UA), N-terminal precursor B-type diuretic peptide (NT-proBNP), and D-dimer (DD) were important independent predictors of VT. The nomogram model correctly separates patients with and without VT, with an optimistic C score of 0.92 (95%CI: 0.90-0.94) and good calibration (Hosmer-Lemeshow χ2 = 11.51, P = 0.12). Our model showed improved prediction of VT compared to CHA2DS2, CHA2DS2-VASc or ATRIA (all P < 0.05). CONCLUSIONS The novel nomogram demonstrated better than presenting scores and showed an improvement in predicting VT in DCM patients.
Collapse
Affiliation(s)
- Xiao-Lei Li
- State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Department of Cardiology, First Affiliated Hospital of Xinjiang Medical University, Urumqi, 830054, Xinjiang, China
- Xinjiang Key Laboratory of Cardiovascular Disease, Clinical Medical Research Institute, First Affiliated Hospital of Xinjiang Medical University, Urumqi, 830054, Xinjiang, China
| | - Dilare Adi
- State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Department of Cardiology, First Affiliated Hospital of Xinjiang Medical University, Urumqi, 830054, Xinjiang, China
- Xinjiang Key Laboratory of Cardiovascular Disease, Clinical Medical Research Institute, First Affiliated Hospital of Xinjiang Medical University, Urumqi, 830054, Xinjiang, China
| | - Yun Wu
- Xinjiang Key Laboratory of Cardiovascular Disease, Clinical Medical Research Institute, First Affiliated Hospital of Xinjiang Medical University, Urumqi, 830054, Xinjiang, China
- State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Department of General Medicine, First Affiliated Hospital of Xinjiang Medical University, Urumqi, 830011, China
| | - Aibibanmu Aizezi
- State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Department of Cardiology, First Affiliated Hospital of Xinjiang Medical University, Urumqi, 830054, Xinjiang, China
- Xinjiang Key Laboratory of Cardiovascular Disease, Clinical Medical Research Institute, First Affiliated Hospital of Xinjiang Medical University, Urumqi, 830054, Xinjiang, China
| | - Yan-Peng Li
- State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Department of Cardiology, First Affiliated Hospital of Xinjiang Medical University, Urumqi, 830054, Xinjiang, China
- Xinjiang Key Laboratory of Cardiovascular Disease, Clinical Medical Research Institute, First Affiliated Hospital of Xinjiang Medical University, Urumqi, 830054, Xinjiang, China
| | - Munawar Kerem
- State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Department of Cardiology, First Affiliated Hospital of Xinjiang Medical University, Urumqi, 830054, Xinjiang, China
- Xinjiang Key Laboratory of Cardiovascular Disease, Clinical Medical Research Institute, First Affiliated Hospital of Xinjiang Medical University, Urumqi, 830054, Xinjiang, China
| | - Xian Wei
- State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Department of Cardiology, First Affiliated Hospital of Xinjiang Medical University, Urumqi, 830054, Xinjiang, China
- Xinjiang Key Laboratory of Cardiovascular Disease, Clinical Medical Research Institute, First Affiliated Hospital of Xinjiang Medical University, Urumqi, 830054, Xinjiang, China
| | - Fen Liu
- State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Department of Cardiology, First Affiliated Hospital of Xinjiang Medical University, Urumqi, 830054, Xinjiang, China
- Xinjiang Key Laboratory of Cardiovascular Disease, Clinical Medical Research Institute, First Affiliated Hospital of Xinjiang Medical University, Urumqi, 830054, Xinjiang, China
| | - Xiang Ma
- State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Department of Cardiology, First Affiliated Hospital of Xinjiang Medical University, Urumqi, 830054, Xinjiang, China.
- Xinjiang Key Laboratory of Cardiovascular Disease, Clinical Medical Research Institute, First Affiliated Hospital of Xinjiang Medical University, Urumqi, 830054, Xinjiang, China.
| | - Yi-Tong Ma
- State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Department of Cardiology, First Affiliated Hospital of Xinjiang Medical University, Urumqi, 830054, Xinjiang, China.
- Xinjiang Key Laboratory of Cardiovascular Disease, Clinical Medical Research Institute, First Affiliated Hospital of Xinjiang Medical University, Urumqi, 830054, Xinjiang, China.
| |
Collapse
|
2
|
Bermudez M, Pedraza L, Guevara N, Erazo G, Valerio FR. Management of a Right Heart Intracavitary Thrombus in Transit in a Patient With Gastric Cancer in a Resource-Limited Setting: A Case Report. Cureus 2023; 15:e43133. [PMID: 37692570 PMCID: PMC10484470 DOI: 10.7759/cureus.43133] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/13/2022] [Accepted: 08/08/2023] [Indexed: 09/12/2023] Open
Abstract
A right atrial thrombus is an unusual source of imminent massive saddle pulmonary embolism (PE) . A hypercoagulable state secondary to gastric cancer (GC) can result in deep vein thrombosis (DVT) with a resultant right-sided heart thrombus in transit. Here, we present a case of a young male patient from Honduras with DVT and multiple venous thrombi extending from the external iliac veins to the suprahepatic left vein, inferior vena cava, and right atrium of the heart, secondary to a hypercoagulable state from GC, adenocarcinoma type. We describe the approach of treating a right heart intracavitary thrombus with imminent risk for saddle PE and sudden cardiac death with thrombolysis through a central venous catheter (CVC) in a resource-limited setting.
Collapse
Affiliation(s)
- Marco Bermudez
- Internal Medicine, St. Barnabas Hospital (SBH) Health System, Bronx, USA
| | - Laura Pedraza
- Internal Medicine, St. Barnabas Hospital (SBH) Health System, Bronx, USA
| | - Nehemias Guevara
- Internal Medicine, St. Barnabas Hospital (SBH) Health System, Bronx, USA
| | - Gloria Erazo
- Internal Medicine, Universidad Católica de Honduras, San Pedro Sula, HND
| | | |
Collapse
|
3
|
Zhai M, Huang L, Liang L, Tian P, Zhao L, Zhao X, Huang B, Feng J, Huang Y, Zhou Q, Zhang Y, Zhang J. Clinical characteristics of patients with heart failure and intracardiac thrombus. Front Cardiovasc Med 2022; 9:934160. [PMID: 36277765 PMCID: PMC9582764 DOI: 10.3389/fcvm.2022.934160] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/02/2022] [Accepted: 09/13/2022] [Indexed: 11/30/2022] Open
Abstract
Background Heart failure (HF) patients are in a hypercoagulable state that predisposes them to an intracardiac thrombus. We aim to assess the clinical features of patients with HF and intracardiac thrombus. Methods Patients diagnosed with HF with intracardiac thrombus were enrolled in this study. Patients' demographics, clinical comorbidities, laboratory tests, and cardiac imaging parameters are recorded. Baseline characteristics are described; the relationship between intracardiac thrombus location and cardiac underlying diseases, New York Heart Association (NYHA) class, and left ventricular ejection fraction (LVEF) are analyzed; and the anticoagulation rate is summarized. Results A total of 1,248 patients were included in the study. Most patients were men (72.2%) with a mean age of 54 years. The left ventricle is the most frequently involved (66.8%), and the prevalence of left ventricular thrombus is more in patients complicated with coronary artery diseases, ventricular noncompaction cardiomyopathy, and dilated cardiomyopathy (86.3%, 86.4%, and 78.2%, respectively). When combined with atrial fibrillation, atrial flutter, hypertrophic cardiomyopathy, restrictive cardiomyopathy, or valvular cardiomyopathy, the intracardiac thrombus is mostly likely to occur in the left atrium. The incidence rate of left cardiac thrombosis increased with the decline of LVEF, an increase of NYHA class, and enlargement of a cardiac chamber. Overall, the anticoagulation rate was 56.8%, with warfarin still the mainstay drug (45.1%), while the prescription of non-vitamin K antagonist oral anticoagulants rose year by year. As for imaging modalities for thrombus detection and diagnosis, transthoracic echocardiography was the most widely performed (75.1%). Conclusion This study summarizes the underlying disease constitution, thrombus location and related factors, imaging modalities, and antithrombotic profile in HF patients with intracardiac thrombus comprehensively.
Collapse
|
4
|
Bugra Z, Emet S, Umman B, Ozer PK, Sezer M, Baykiz D, Atilgan D, Tireli E, Dursun M, Yılmazbayhan D, Karaayvaz EB, Elitok A, Bilge AK, Goren T, Umman S, Kumrular M, Yilmaz M, Sonsoz MR, Engin B, Ayduk E, Aydogan M, Cevik E, Kavak I, Orta H, Tasdemir M, Tuncozgur A, Topcak Z, Gorgun OD, Oztas DM. Intracardiac masses: Single center experience within 12 years: I-MASS Study. AMERICAN HEART JOURNAL PLUS : CARDIOLOGY RESEARCH AND PRACTICE 2022; 13:100081. [PMID: 38560087 PMCID: PMC10978191 DOI: 10.1016/j.ahjo.2021.100081] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 10/22/2021] [Revised: 11/27/2021] [Accepted: 12/07/2021] [Indexed: 04/04/2024]
Abstract
Objective The aim of this cross-sectional, retrospective, descriptive study was to review and classify cardiac masses systematically and to determine their frequencies. Methods The medical records of 64,862 consecutive patients were investigated within 12 years. Every patient with a cardiac mass imaged by transthoracic echocardiography (TTE) and confirmed with an advanced imaging modality such as transesophageal echocardiography (TEE), computed tomography (CT) and/or cardiac magnetic resonance imaging (CMR) was included. Acute coronary syndromes triggering thrombus formation, vegetations, intracardiac device and catheter related thrombi were excluded. Results Data demonstrated 127 (0.195%) intracardiac masses consisting of 33 (0.050%) primary benign, 3 (0.004%) primary malignant, 20 (0.030%) secondary tumors, 3 (0.004%) hydatid cysts and 68 (0.104%) thrombi respectively. The majority of primary cardiac tumors were benign (91.67%), predominantly myxomas (78.79%), and the less malignant (8.33%). Secondary cardiac tumors were common than the primary malignant tumors (20:3), with male dominancy (55%), lymphoma and lung cancers were the most frequent. Intracardiac thrombi was the majority of the cardiac masses, thrombi accompanying malignancies were in the first range (n = 17, 25%), followed by autoimmune diseases (n = 13, 19.12%) and ischemic heart disease with low ejection fraction (n = 12, 17.65%). Conclusions This retrospective analysis identified 127 patients with cardiac masses. The majority of benign tumors were myxoma, the most common tumors that metastasized to the heart were lymphoma and lung cancers, and the thrombi associated with malignancies and autoimmune diseases were the most frequent.
Collapse
Affiliation(s)
- Zehra Bugra
- Istanbul University, Istanbul Medical Faculty, Department of Cardiology, Turkey
| | - Samim Emet
- Istanbul University, Istanbul Medical Faculty, Department of Cardiology, Turkey
| | - Berrin Umman
- Istanbul University, Istanbul Medical Faculty, Department of Cardiology, Turkey
| | - Pelin Karaca Ozer
- Istanbul University, Istanbul Medical Faculty, Department of Cardiology, Turkey
| | - Murat Sezer
- Istanbul University, Istanbul Medical Faculty, Department of Cardiology, Turkey
| | - Derya Baykiz
- Istanbul University, Istanbul Medical Faculty, Department of Cardiology, Turkey
| | - Dursun Atilgan
- Istanbul University, Istanbul Medical Faculty, Department of Cardiology, Turkey
| | - Emin Tireli
- Istanbul University, Istanbul Medical Faculty, Department of Cardiovascular Surgery, Turkey
| | - Memduh Dursun
- Istanbul University, Istanbul Medical Faculty, Department of Radiology, Turkey
| | - Dilek Yılmazbayhan
- Istanbul University, Istanbul Medical Faculty, Department of Pathology, Turkey
| | | | - Ali Elitok
- Istanbul University, Istanbul Medical Faculty, Department of Cardiology, Turkey
| | - Ahmet Kaya Bilge
- Istanbul University, Istanbul Medical Faculty, Department of Cardiology, Turkey
| | - Taner Goren
- Istanbul University, Istanbul Medical Faculty, Department of Cardiology, Turkey
| | - Sabahattin Umman
- Istanbul University, Istanbul Medical Faculty, Department of Cardiology, Turkey
| | - Collaborators
- Istanbul University, Istanbul Medical Faculty, Department of Cardiology, Turkey
- Istanbul University, Istanbul Medical Faculty, Department of Cardiovascular Surgery, Turkey
- Istanbul University, Istanbul Medical Faculty, Department of Radiology, Turkey
- Istanbul University, Istanbul Medical Faculty, Department of Pathology, Turkey
| | - Merve Kumrular
- Istanbul University, Istanbul Medical Faculty, Department of Cardiology, Turkey
| | - Mustafa Yilmaz
- Istanbul University, Istanbul Medical Faculty, Department of Cardiology, Turkey
| | - Mehmet Rasih Sonsoz
- Istanbul University, Istanbul Medical Faculty, Department of Cardiology, Turkey
| | - Berat Engin
- Istanbul University, Istanbul Medical Faculty, Department of Cardiology, Turkey
| | - Elif Ayduk
- Istanbul University, Istanbul Medical Faculty, Department of Cardiology, Turkey
| | - Mehmet Aydogan
- Istanbul University, Istanbul Medical Faculty, Department of Cardiology, Turkey
| | - Erdem Cevik
- Istanbul University, Istanbul Medical Faculty, Department of Cardiology, Turkey
| | - Ilyas Kavak
- Istanbul University, Istanbul Medical Faculty, Department of Cardiology, Turkey
| | - Huseyin Orta
- Istanbul University, Istanbul Medical Faculty, Department of Cardiology, Turkey
| | - Mucahit Tasdemir
- Istanbul University, Istanbul Medical Faculty, Department of Cardiology, Turkey
| | - Asli Tuncozgur
- Istanbul University, Istanbul Medical Faculty, Department of Cardiology, Turkey
| | - Zeynep Topcak
- Istanbul University, Istanbul Medical Faculty, Department of Cardiology, Turkey
| | - Ozerk Dogus Gorgun
- Istanbul University, Istanbul Medical Faculty, Department of Pathology, Turkey
| | - Didem Melis Oztas
- Istanbul University, Istanbul Medical Faculty, Department of Cardiovascular Surgery, Turkey
| |
Collapse
|
5
|
Belov IV, Nechaenko MA, Kuznetsova LM, Khovrin VV, Fedorov DN, Kiprenskiĭ AI, Dombrovskaia AV. [Solid lesions of heart valves]. Khirurgiia (Mosk) 2016:11-18. [PMID: 26977862 DOI: 10.17116/hirurgia2016211-18] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
AIM To analyze clinical-diagnostic and surgical aspects of cardiac valve solid lesions as well as long-term results of surgical treatment. MATERIAL AND METHODS Clinical, diagnostic and surgical aspects of treatment of 51 patients with tumorous and pseudotumorous lesions of cardiac valves were analyzed. RESULTS AND DISCUSSION Hospital complications were observed in 17.7% of patients. Mortality rate was 3.9%. 1- and 28-year overall survival was 100% and 94.1% respectively. Quality of life was good, satisfactory and unsatisfactory in 73.5%, 20.4% and 6.1% of cases respectively. CONCLUSION Timely diagnostics of tumorous and pseudotumorous lesions of cardiac valves is very difficult but possible based on short history, positional dependence of symptoms, embolic events without rhythm disturbances. Additional instrumental methods including TTE, TEE, CT and MRI are necessary to define diagnosis. Intraoperative diagnostics and immediate histological survey are useful to determine volume of surgery in each case. Successful surgical treatment implies urgency, hypothermic perfusion and pharmaco-cold cardioplegia during operation.
Collapse
Affiliation(s)
- Iu V Belov
- B.V. Petrovsky Russian Research Center of Surgery, Moscow
| | - M A Nechaenko
- B.V. Petrovsky Russian Research Center of Surgery, Moscow
| | - L M Kuznetsova
- B.V. Petrovsky Russian Research Center of Surgery, Moscow
| | - V V Khovrin
- B.V. Petrovsky Russian Research Center of Surgery, Moscow
| | - D N Fedorov
- B.V. Petrovsky Russian Research Center of Surgery, Moscow
| | | | | |
Collapse
|
6
|
Girolami A, de Marinis GB, Treleani M, Tasinato V, Girolami B. Congenital Thrombophilia and Intracardiac Thrombosis: Probably an Underdiagnosed Event. Cardiol Res 2013; 4:109-115. [PMID: 28352430 PMCID: PMC5358248 DOI: 10.4021/cr278e] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 05/27/2013] [Indexed: 11/05/2022] Open
Abstract
Background To investigate the number of patients with congenital thrombophilia who presented an intracardiac thrombosis. Methods Personal files were reevaluated together with a time-unlimited search of the literature. Results Twenty-five patients with intracardiac thrombosis and congenital thrombophilia have been gathered from the literature including the two personal cases. The distribution observed in thrombophilia patients is similar for left side or right side heart (9 vs 11 cases). The left ventricle and the right ventricle were involved in six or five instances, respectively. In one case, both ventricles were involved. On the contrary, the left atrium was involved in three cases whereas the right atrium was affected in six cases. In the remaining cases, more than one heart chamber was involved. Conclusions In “normal” subjects, left side thromboses are predominant once catheter-associated thrombi are excluded. The reason of this discrepancy lies in the greater prothrombotic effect exercised by congenital thrombophilia on venous thrombosis compared to arterial thrombosis. The relative high prevalence of cardiac thrombosis seen in patients with antithrombin and protein C deficiencies indicated that a cardiac evaluation should be carried out in all patients with these two defects.
Collapse
Affiliation(s)
- Antonio Girolami
- Department of Medicine, University of Padua, Medical School, Padua, Italy
| | | | - Martina Treleani
- Department of Medicine, University of Padua, Medical School, Padua, Italy
| | - Valentina Tasinato
- Department of Medicine, University of Padua, Medical School, Padua, Italy
| | - Bruno Girolami
- Division of General Medicine, Padua City Hospital, Padua, Italy
| |
Collapse
|